Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,108 | -16,561 | -59,016 | -46,674 | -33,055 |
| Depreciation Amortization | 174 | 88 | 567 | 495 | 328 |
| Accounts receivable | -781 | -301 | 321 | 321 | 281 |
| Other Working Capital | -2,225 | -2,306 | -399 | -1,651 | -1,936 |
| Other Operating Activity | 2,986 | 1,934 | 1,822 | 4,470 | 4,127 |
| Operating Cash Flow | $-29,954 | $-17,146 | $-56,705 | $-43,039 | $-30,255 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 14,478 | 9,978 | 208 |
| PPE Investments | -35 | -9 | -177 | -137 | -55 |
| Investing Cash Flow | $-35 | $-9 | $14,301 | $9,841 | $153 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 56,153 | 56,165 | 58,243 |
| Financing Cash Flow | $N/A | $N/A | $56,153 | $56,165 | $58,243 |
| Beginning Cash Position | 74,562 | 74,562 | 60,813 | 60,813 | 60,813 |
| End Cash Position | 44,573 | 57,407 | 74,562 | 83,780 | 88,954 |
| Net Cash Flow | $-29,989 | $-17,155 | $13,749 | $22,967 | $28,141 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,954 | -17,146 | -56,705 | -43,039 | -30,255 |
| Capital Expenditure | -35 | -9 | -177 | -137 | -55 |
| Free Cash Flow | -29,989 | -17,155 | -56,882 | -43,176 | -30,310 |